Analysis ImmunityBio Shares Swing as Clinical Progress Meets Market Turbulence
ImmunityBio investors experienced a rollercoaster week, with the company’s stock exhibiting extreme volatility against a backdrop of significant operational achievements. The divergence between strong fundamental developments and a whipsawing share...